Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0446
-0.0004 (-0.89%)
Mar 12, 2026, 5:30 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 5.2 million as of March 12, 2026. Its market cap has decreased by -5.91% in one year.
Market Cap
5.20M
Enterprise Value
3.05M
Revenue
158.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 5.20M, a decrease of -98.70%. That is a compound annual growth rate of -20.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 5.25M | -18.77% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.02B |
| Basilea Pharmaceutica AG | 649.00M |
| Newron Pharmaceuticals | 363.28M |
| Santhera Pharmaceuticals Holding AG | 237.31M |
| Xlife Sciences AG | 140.73M |
| Molecular Partners AG | 140.25M |
| BioVersys AG | 135.09M |
| EvoNext Holdings | 6.35M |